Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

FDA Approves New Dosage Strength for INTELENCE

By Pharmaceutical Processing | January 3, 2011

The FDA has approved a label
update to include a 200 mg formulation of INTELENCE (etravirine), a
non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for the
treatment of human immunodeficiency virus (HIV-1) in treatment-experienced
adults with resistance to an NNRTI and other antiretroviral (ARV) agents.

The recommended oral dose of
INTELENCE tablets is 200 mg (one 200 mg tablet or two 100 mg tablets) taken
twice daily following a meal. The new 200 mg product formulation is expected to
launch in the U.S.
later this month, and the 100 mg tablet will remain available. Patients who are
unable to swallow INTELENCE tablets whole may disperse the tablets in a glass
of water.

The FDA granted accelerated
approval to INTELENCE in January 2008, and it has since been approved in more
than 65 countries. INTELENCE received traditional FDA approval in November
2009, based on 48-week data from the DUET-1 and DUET-2 studies, and is currently
marketed in the U.S.
by Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P.

 

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE